ong-term effects of dapagliflozin, a SGLT2 inhibitor, on glucose metabolism in patients with type 2 diabetes mellitus
Not Applicable
Recruiting
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000026042
- Lead Sponsor
- Kurume University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Repeated urinary tract infection HbA1c < 7.0% BMI < 22
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fasting blood glucose, HbA1c, urinary sugar
- Secondary Outcome Measures
Name Time Method